Skip to content
RDL Network logo
1527TiP CONGRATS-combination of nivolumab plus relatlimab in patients with advanced or metastatic soft-tissue sarcoma: A proof-of-concept randomized phase II study — Mariella Spalato Ceruso (2022) | RDL Network